The goal of treating Parkinson's disease must be quality of life and needs to be the main priority of patients and medical professionals alike.
When you enter the world of clinical research for Parkinson's or any other condition, it is important to understand the terms that are being used to describe the details of the clinical trial.
Like any decision, whether or not you participate in a Parkinson's clinical trial requires careful consideration of the pros and cons as they relate to a particular study.
Clinical trial recruitment in Parkinson's research delays the development of new treatments. But there are resources that help patients connect with the right study.
The term "clinical trials" can mean everything from a questionnaire to testing out a new drug for the first time. But all trials need participants.
As patients we are key to successful Parkinson's research. Without us better treatments and a cure will not be found - the importance of clinical trials.
The journey of a drug or intervention to help treat Parkinson's disease is a long and complicated one. Learn how a new medication gets to the pharmacy shelf.
Participating in a clinical trial is a much needed action but there are many questions that you may have before joining a study. Here are some common ones.
Mood disorders are fairly common in those affected by Parkinson's disease and must be identified and treated in order to improve quality of life.
Mood disorders are more prevalent in the Parkinson's community and are sometimes difficult to diagnose. But early management is key when considering quality of life.